Pathology of human bladder cancer and related lesions

Gilbert H. Friedell, George K. Nagy, Samuel Monroe Cohen

Research output: Chapter in Book/Report/Conference proceedingChapter

7 Citations (Scopus)

Abstract

The lower urinary tract consists of the renal pelves, ureters, urinary bladder, and urethra. It is lined by a distinctive epithelium as described below and functions as a passageway and a storage area for the excretion of urine. Tumors of the lower urinary tract are fairly common, particularly in males, making up over 4% of all new cancers in the U.S. each year. The classification of these tumors should have been a rather simple matter, since they are readily accessible for clinical and morphological examination, their structural variation is limited, and there is an extensive literature describing their morphology, biology, and treatment. Despite the suggestions of many authors, however, there is today no generally accepted system for the classification of these tumors. A bewildering variety of terms have been used in the literature, and comparisons of the biology and of the treatment results between one series of cases and another is difficult. In this review, we will briefly describe some of the classification systems that have been proposed, then focus on one which has been used for the past few years in the Central Pathology Laboratory of the National Bladder Cancer Collaborative Group A, an aggregate of investigators representing some ten institutions entering patients into a cooperative study. Certain less-common benign and neoplastic lesions occurring in the lower urinary tract will be discussed as well as some of the technical aspects of processing and examining these samples.

Original languageEnglish (US)
Title of host publicationPathology of Bladder Cancer
PublisherCRC Press
Pages11-42
Number of pages32
ISBN (Electronic)9781351359559
ISBN (Print)9781138505186
DOIs
StatePublished - Jan 1 2017

Fingerprint

Urinary Bladder Neoplasms
Urinary Tract
Pathology
Neoplasms
Kidney Pelvis
Urethra
Ureter
Urinary Bladder
Epithelium
Research Personnel
Urine
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Friedell, G. H., Nagy, G. K., & Cohen, S. M. (2017). Pathology of human bladder cancer and related lesions. In Pathology of Bladder Cancer (pp. 11-42). CRC Press. https://doi.org/10.1201/9780203711156

Pathology of human bladder cancer and related lesions. / Friedell, Gilbert H.; Nagy, George K.; Cohen, Samuel Monroe.

Pathology of Bladder Cancer. CRC Press, 2017. p. 11-42.

Research output: Chapter in Book/Report/Conference proceedingChapter

Friedell, GH, Nagy, GK & Cohen, SM 2017, Pathology of human bladder cancer and related lesions. in Pathology of Bladder Cancer. CRC Press, pp. 11-42. https://doi.org/10.1201/9780203711156
Friedell GH, Nagy GK, Cohen SM. Pathology of human bladder cancer and related lesions. In Pathology of Bladder Cancer. CRC Press. 2017. p. 11-42 https://doi.org/10.1201/9780203711156
Friedell, Gilbert H. ; Nagy, George K. ; Cohen, Samuel Monroe. / Pathology of human bladder cancer and related lesions. Pathology of Bladder Cancer. CRC Press, 2017. pp. 11-42
@inbook{20dd219db1634c82925803987e3db77c,
title = "Pathology of human bladder cancer and related lesions",
abstract = "The lower urinary tract consists of the renal pelves, ureters, urinary bladder, and urethra. It is lined by a distinctive epithelium as described below and functions as a passageway and a storage area for the excretion of urine. Tumors of the lower urinary tract are fairly common, particularly in males, making up over 4{\%} of all new cancers in the U.S. each year. The classification of these tumors should have been a rather simple matter, since they are readily accessible for clinical and morphological examination, their structural variation is limited, and there is an extensive literature describing their morphology, biology, and treatment. Despite the suggestions of many authors, however, there is today no generally accepted system for the classification of these tumors. A bewildering variety of terms have been used in the literature, and comparisons of the biology and of the treatment results between one series of cases and another is difficult. In this review, we will briefly describe some of the classification systems that have been proposed, then focus on one which has been used for the past few years in the Central Pathology Laboratory of the National Bladder Cancer Collaborative Group A, an aggregate of investigators representing some ten institutions entering patients into a cooperative study. Certain less-common benign and neoplastic lesions occurring in the lower urinary tract will be discussed as well as some of the technical aspects of processing and examining these samples.",
author = "Friedell, {Gilbert H.} and Nagy, {George K.} and Cohen, {Samuel Monroe}",
year = "2017",
month = "1",
day = "1",
doi = "10.1201/9780203711156",
language = "English (US)",
isbn = "9781138505186",
pages = "11--42",
booktitle = "Pathology of Bladder Cancer",
publisher = "CRC Press",

}

TY - CHAP

T1 - Pathology of human bladder cancer and related lesions

AU - Friedell, Gilbert H.

AU - Nagy, George K.

AU - Cohen, Samuel Monroe

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The lower urinary tract consists of the renal pelves, ureters, urinary bladder, and urethra. It is lined by a distinctive epithelium as described below and functions as a passageway and a storage area for the excretion of urine. Tumors of the lower urinary tract are fairly common, particularly in males, making up over 4% of all new cancers in the U.S. each year. The classification of these tumors should have been a rather simple matter, since they are readily accessible for clinical and morphological examination, their structural variation is limited, and there is an extensive literature describing their morphology, biology, and treatment. Despite the suggestions of many authors, however, there is today no generally accepted system for the classification of these tumors. A bewildering variety of terms have been used in the literature, and comparisons of the biology and of the treatment results between one series of cases and another is difficult. In this review, we will briefly describe some of the classification systems that have been proposed, then focus on one which has been used for the past few years in the Central Pathology Laboratory of the National Bladder Cancer Collaborative Group A, an aggregate of investigators representing some ten institutions entering patients into a cooperative study. Certain less-common benign and neoplastic lesions occurring in the lower urinary tract will be discussed as well as some of the technical aspects of processing and examining these samples.

AB - The lower urinary tract consists of the renal pelves, ureters, urinary bladder, and urethra. It is lined by a distinctive epithelium as described below and functions as a passageway and a storage area for the excretion of urine. Tumors of the lower urinary tract are fairly common, particularly in males, making up over 4% of all new cancers in the U.S. each year. The classification of these tumors should have been a rather simple matter, since they are readily accessible for clinical and morphological examination, their structural variation is limited, and there is an extensive literature describing their morphology, biology, and treatment. Despite the suggestions of many authors, however, there is today no generally accepted system for the classification of these tumors. A bewildering variety of terms have been used in the literature, and comparisons of the biology and of the treatment results between one series of cases and another is difficult. In this review, we will briefly describe some of the classification systems that have been proposed, then focus on one which has been used for the past few years in the Central Pathology Laboratory of the National Bladder Cancer Collaborative Group A, an aggregate of investigators representing some ten institutions entering patients into a cooperative study. Certain less-common benign and neoplastic lesions occurring in the lower urinary tract will be discussed as well as some of the technical aspects of processing and examining these samples.

UR - http://www.scopus.com/inward/record.url?scp=85053357915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053357915&partnerID=8YFLogxK

U2 - 10.1201/9780203711156

DO - 10.1201/9780203711156

M3 - Chapter

AN - SCOPUS:85053357915

SN - 9781138505186

SP - 11

EP - 42

BT - Pathology of Bladder Cancer

PB - CRC Press

ER -